David S. Barlow

Mr. Barlow is Chairman and CEO of Molecular Insight Pharmaceuticals, Inc. Molecular Insight is an emerging biopharmaceutical company focused on developing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics for cancer. He joined Molecular Insight in March 2000 as Chairman and added the CEO responsibilities in January 2003.

David Barlow’s has over twenty-five years of distinguished service in the global biopharmaceutical industry that includes building high performance companies and developing, launching and marketing successful products in the US and global market. Mr. Barlow was previously President, Pharmaceuticals, Sepracor Inc. where he was instrumental in the conception and implementation of a strategy that created the first fully integrated chemistry-based pharmaceutical company in decades. During his six-year tenure, which ended in late 1999, Sepracor’s valuation increased from roughly $80 million to nearly $5 billion. Over this period Sepracor Pharmaceuticals grew from thirty employees to several hundred; including a full R&D, sales and marketing capability. Substantial corporate partnerships were also created with companies such as Schering-Plough, Eli Lilly and J&J, and over $500 million was raised in the public markets.

From 1988 to 1991, Mr. Barlow was responsible for transforming Rhone-Poulenc Rorer’s global Armour Division from an unprofitable commodity business into the corporation’s most profitable entity by redefining and rebuilding the business based on novel strategies. He has also held management positions in business development, planning and marketing for Rorer Group, Pfizer Inc., and the ARES Serono Group.

Mr. Barlow serves as a Trustee of Bates College, McLean Hospital, and Newton Country Day School and is a member of the President’s Council at Massachusetts General Hospital. He earned his M.B.A. from Stanford University Graduate School of Business where he is a frequent lecturer on strategic public policy and the biopharmaceutical industry. He also earned his B.A. from Bates College.